Original article
ASDAS high disease activity versus BASDAI elevation in patients with ankylosing spondylitis as selection criterion for anti-TNF therapy
Actividad elevada ASDAS versus elevación de BASDAI en pacientes con espondilitis anquilosante como criterio de selección para el tratamiento con anti TNF-alfa
Nathan Vastesaegera,
, Bert Vander Cruyssenb, Juan Muleroc, Jordi Gratacós Masmitjád, Pedro Zarcoe, Raquel Almodovare, Pilar Fontf, Xavier Juanolag, Eduardo Collantes-Estevezf, on behalf of the REGISPONSER Working Group
Corresponding author
a Merck Sharp & Dohme, Brussels, Belgium
b Rheumatology Service, Ghent University Hospital, Ghent, Belgium
c Servicio de Reumatología, Hospital Puerta de Hierro, Madrid, Spain
d Servicio de Reumatología, Hospital Parc Taulí, Sabadell, Barcelona, Spain
e Servicio de Reumatología, Hospital Fundación de Alcorcón, Madrid, Spain
f Rheumatology Service, Reina Sofia University Hospital/IMIBIC and University of Córdoba, Spain
g Servicio de Reumatología, Hospital Universitario de Bellvitge, Barcelona, Spain
Read
12721
Timeswas read the article
2995
Total PDF
9726
Total HTML
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 12 | 13 | 25 |
| 2025 5 | 272 | 57 | 329 |
| 2025 4 | 182 | 43 | 225 |
| 2025 3 | 192 | 52 | 244 |
| 2025 2 | 141 | 64 | 205 |
| 2025 1 | 164 | 57 | 221 |
| 2024 12 | 116 | 53 | 169 |
| 2024 11 | 116 | 84 | 200 |
| 2024 10 | 105 | 38 | 143 |
| 2024 9 | 141 | 36 | 177 |
| 2024 8 | 145 | 43 | 188 |
| 2024 7 | 149 | 41 | 190 |
| 2024 6 | 157 | 41 | 198 |
| 2024 5 | 159 | 43 | 202 |
| 2024 4 | 127 | 35 | 162 |
| 2024 3 | 140 | 40 | 180 |
| 2024 2 | 217 | 24 | 241 |
| 2024 1 | 264 | 25 | 289 |
| 2023 12 | 149 | 34 | 183 |
| 2023 11 | 123 | 29 | 152 |
| 2023 10 | 143 | 36 | 179 |
| 2023 9 | 127 | 40 | 167 |
| 2023 8 | 65 | 13 | 78 |
| 2023 7 | 84 | 29 | 113 |
| 2023 6 | 61 | 40 | 101 |
| 2023 5 | 67 | 20 | 87 |
| 2023 4 | 52 | 9 | 61 |
| 2023 3 | 94 | 24 | 118 |
| 2023 2 | 89 | 27 | 116 |
| 2023 1 | 55 | 17 | 72 |
| 2022 12 | 96 | 58 | 154 |
| 2022 11 | 116 | 28 | 144 |
| 2022 10 | 118 | 32 | 150 |
| 2022 9 | 89 | 27 | 116 |
| 2022 8 | 117 | 47 | 164 |
| 2022 7 | 152 | 37 | 189 |
| 2022 6 | 78 | 34 | 112 |
| 2022 5 | 119 | 51 | 170 |
| 2022 4 | 182 | 40 | 222 |
| 2022 3 | 206 | 50 | 256 |
| 2022 2 | 353 | 17 | 370 |
| 2022 1 | 260 | 36 | 296 |
| 2021 12 | 242 | 41 | 283 |
| 2021 11 | 194 | 45 | 239 |
| 2021 10 | 220 | 49 | 269 |
| 2021 9 | 128 | 48 | 176 |
| 2021 8 | 113 | 39 | 152 |
| 2021 7 | 120 | 31 | 151 |
| 2021 6 | 54 | 48 | 102 |
| 2021 5 | 81 | 53 | 134 |
| 2021 4 | 88 | 65 | 153 |
| 2021 3 | 87 | 21 | 108 |
| 2021 2 | 112 | 31 | 143 |
| 2021 1 | 89 | 24 | 113 |
| 2020 12 | 69 | 25 | 94 |
| 2020 11 | 61 | 24 | 85 |
| 2020 10 | 39 | 14 | 53 |
| 2020 9 | 53 | 27 | 80 |
| 2020 8 | 41 | 19 | 60 |
| 2020 7 | 39 | 17 | 56 |
| 2020 6 | 48 | 18 | 66 |
| 2020 5 | 75 | 26 | 101 |
| 2020 4 | 175 | 22 | 197 |
| 2020 3 | 54 | 9 | 63 |
| 2020 2 | 1 | 0 | 1 |
| 2019 5 | 1 | 0 | 1 |
| 2019 2 | 2 | 0 | 2 |
| 2018 5 | 5 | 1 | 6 |
| 2018 4 | 66 | 17 | 83 |
| 2018 3 | 68 | 16 | 84 |
| 2018 2 | 41 | 11 | 52 |
| 2018 1 | 32 | 7 | 39 |
| 2017 12 | 41 | 10 | 51 |
| 2017 11 | 36 | 33 | 69 |
| 2017 10 | 45 | 32 | 77 |
| 2017 9 | 36 | 26 | 62 |
| 2017 8 | 41 | 26 | 67 |
| 2017 7 | 41 | 26 | 67 |
| 2017 6 | 43 | 40 | 83 |
| 2017 5 | 58 | 30 | 88 |
| 2017 4 | 34 | 35 | 69 |
| 2017 3 | 35 | 50 | 85 |
| 2017 2 | 35 | 22 | 57 |
| 2017 1 | 28 | 28 | 56 |
| 2016 12 | 58 | 22 | 80 |
| 2016 11 | 52 | 21 | 73 |
| 2016 10 | 68 | 29 | 97 |
| 2016 9 | 86 | 18 | 104 |
| 2016 8 | 92 | 20 | 112 |
| 2016 7 | 64 | 39 | 103 |
| 2016 4 | 1 | 0 | 1 |
| 2016 2 | 1 | 0 | 1 |
| 2015 12 | 1 | 0 | 1 |
| 2015 9 | 1 | 0 | 1 |
| 2015 8 | 3 | 0 | 3 |
| 2015 7 | 25 | 8 | 33 |
| 2015 6 | 48 | 8 | 56 |
| 2015 5 | 69 | 10 | 79 |
| 2015 4 | 55 | 13 | 68 |
| 2015 3 | 47 | 15 | 62 |
| 2015 2 | 79 | 8 | 87 |
| 2015 1 | 65 | 22 | 87 |
| 2014 12 | 78 | 9 | 87 |
| 2014 11 | 45 | 15 | 60 |
| 2014 10 | 30 | 11 | 41 |
| 2014 9 | 35 | 18 | 53 |
| 2014 8 | 22 | 20 | 42 |
| 2014 7 | 36 | 19 | 55 |
Show all
